1

- 1

:

I.

, : . 01/04-2.1126-1/16

08.04.2016.

/ :

:

2 ( )

2 ( )

: 13.04.2016.

: ) - . ,

, -

2

) - . ,

, ) - . ,

, - )

, ,

II.

) : ( ) : ( , )

: 02.06.1964. :

, , - ,

: , , - ,

,

:

( );

;

,

( );

(European Association of Urology EAU).

) :

: :

3

: , 1989. : 8,63

: : ,

: : , 2001. : “

“ / (

): ( )

: 9,2 / :

:

:

, 2004.

: „

“

/ ( ):

( )

( , , )

- ,

05-41/02, 24.01.2002.

(5) ,

-

,

05-167/05 21.06.2005. , (5) .

-

,

05-3071-XXXVIII-14.4.7/10 15.07.2010. ,

, .

4

025 22.05.2012.

) /

/

( .19, . 3)

: . : ; 2009.

(10 )

( .19, .11)

, , .

: - VII. : ,

; 2007: 57-80. (10 )

, , , . . Scr. Medica 2006; 37(1): 37-45.

(0,75x10 = 7,5 )

( .19, .8)

. Ultrasound Estimated Bladder W ight During the Treatment of Benign Prostatic Hyperplasia with Tamsulosin. Acta informatica medica 2008;16(4):210-14. (10 )

. . 2009; 63(1):19-23.

(10 )

, . .

2010; 67(1):1-4. (10 )

5

, , , . Omnic i Tonocardin-kom , dicinski žurnal 2009; 15(3): 111-16. (0,75x10 = 7,5 bodova)

. . edicinski žurnal

2009;15(1-2):23-28 (10 bodova)

, , , , . , ARCHIVUM UROLOGICUM 2002.; 66-

67 (24):89-92. (0,5x10 = 5 )

, , , . . Acta chir Jug 2001;Suppl1(425):23-7.

(0,75x10 = 7,5 )

, , . (1996.-2000.), Medical Arts 2001;61-66.

(10 )

( . 19, .13)

. .

(8 )

, XVIII EAU-ESU (European Association of

Urology-European School of Urology) , 2007. O ( .19,

.9)

, , . . Scr. Medica 2007; 38(1): 51-7.

(6 )

6

, , . tamsulosina . Medici Com. 2005;12:72-76.

(6 )

, ( .19, . 15)

, . . „ , , , “. ; 2008:135-138.

(5 )

, . . „ , , , “. ; 2008:139-

142. (5 )

, , - . ESWL i URS – .

„ , , , “. ; 2009:15-22. (5 )

, , . . „ ,

, , “. ; 2009:15-22. (5 )

, , . . „ “.

; 2005: 57-63. (5 )

, , . . „ “. ; 2005:

79-87. (5 )

, , . . " ".

2003;4:72-80. (5 )

, - , , , , . . .

2003;2/II:184-191. (0,3x5 = 1,5 )

7

- , , , , .

. V K . ; 2003:103-105.

(0,5x5 = 2,5 ) , , - , , , ,

. . .

2003; 4:23-9. (0,3x5 = 1,5 )

, , , . . . 2003;4:201-9.

(0,75x5 = 3,75 )

, , , , - , , , . . . 2003;4:210-13.

(0,3x5 = 1,5 )

, , , . . .

2001;2:30-37. (0,75x5 = 3,75 )

, , . . .

2001;2:23-30. (5 )

, , . . . . 2001;2:384-7.

(5 )

, , , , , , - . .

. 2001;2:93-7. (0,3x5 =1,5 )

, , , , - , , . .

. 2001;2:87-92 (0,3x5 =1,5 )

8

, , , , .

. . 2001;2:42-52. (0,50x5 = 2,5 )

, ( -19, .16)

, , - . Efficiancy of the finasteride to decreasing IPSS.II Congress of the Balcans Urologists, Macedonia. ; 2001:4-8 (3 )

, , , , .

- . II . 1996: 375. (0,5x3 =1,5 )

/

( . 19, .3)

. . :

; 2016.

, ,

, ,

. , ,

, , ,

.

, , , ,

, .

, . ,

9

. ,

, , .

(10 )

( . 19, .8) M . The impact of Benign Prostatic hyperplasia Surgical Treatment with TURP Method on the Quality of Life. Acta Informatica Medica (AIM) 2011; 19(3): 142-145.

( ) , , ( )

( ). - , ,

. 40 , ( ). International Prostate Symptom Score

(IPSS) , .

IPSS, , 4, 8 12 .

, , - Wilcoxon

.

, , .

(10 )

M , , . The Evaluation of Impact of BPH Surgical Treatment with the Open Prostatectomy and transurethral resection of the Prostate Methods on the Quality of Life. Medical Arhives (Med Arh) 2011; 65(5): 275-279.

( ) .

( ) ( ) .

80 , 40 ( ), 40 ( ).

70,23 , 69,73 , International Prostate Symptome

10

Score IPSS >19 , 150 , 30 , 80 .

, , , IPSS.

, , 4, 8 12 .

, .

, .

. (10 )

, , , . Selection of Treatment Method for Pelvic Ring Fractures. Med Arh. 2011; 65(5): 279-283.

-

, , . 47

, 1999.-2009. . Marvin Tile’s classification, : Type A 19

(40,6%), Type 18 (38,1%), Type 10 (21,3%). 26 (56,2%)

, 21 (43,8%) . (x-rays

according t Slatis), D’Aubigne-Postel scale, 18 .

, Tile’s Type A fractures,

Type B fractures (including all subtypes), ,

, Type C2 and Type C3 fractures.

, .

(0,75x10 = 7,5 )

, . The Activity of Mitochondrial Superoxide Dismuitase in Normal and Pathological Endometrium and Correlation with the Hormonal status of Women. Med Arh. 2011; 65(6): 321-330.

superoxide dismutase mitochondria (MnSOD-e) ,

11

MnSOD . 70 , 30 ( -

) 40 , endometrial hyperplasia or endometrium carcinoma

( - ). 41-50 . ,

( , , , ),

, ( MnSOD-e,

). MnSOD enzyme

(0,93) (1,94) (1,27) (2,79). MnSOD enzyme

, ,

. MnSOD enzyme , , .

MnSOD enzyme , ,

. (10 )

, . Efficacy and safety of Tamsulosin in the Treatment of Benign Prostatic Hyperplasia. Med Arh. 2012; 66(3): 148-54.

0,4

( ), ( ). 45 , ,

International Prostate Symptom Score (IPSS) 8 , Quality of Life Index (QLI), 3 .

0,4 12 . IPSS QLI,

, . , IPSS

24,95 , 4- 16,09 , 11,20 12- . , IPSS 35,51% 4- , 55,11% 12-

. Quality of Life Index 4,49 , 4 2,49 , 1,40 12- .

IPSS QLI (p<0.05).

12

3 (6,66%), (2,22%), 2 (4,44%) ,

. 12-

- , , .

(10 )

. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight. Med Arh. 2012; 66(6): 391-395.

( ),

0,4 . , , . 20 ,

45 , ( ) , 3 .

International Prostate Symptom Score (IPSS) 8 , 100

( ) 4 / . 0,4 . 4, 12 24

. .

(UEWB), , , IPSS, - e o

(I-IPSS), te (O-IPSS), (IPSS-QoL), , ,

. 24- -

, . ( 65 . 28 .).

(10 )

, , - , . Treatment of Vesicovaginal Fistulas: an Experience of 30 Cases. Med Arh. 2013; 67(4): 266-269.

( ) ,

30 . 30

, 2004.-2012. . 19 , 1

, .

13

14 .

(75%), 100% .

40%. ,

. 100%.

6 , .

.

, , .

(0,75x10 = 7,5 )

, , , , - , . Correlation of the Body Mass Index and Calcium Nephrolithiasis in Adult Population. Med Arh. 2013; 67(6): 417-422.

, Body Mass Index (BMI)

, . ,

, 2012.- 2013. . 120

( ) 120 ( ). BMI

, , Center for Disease Control and Prevention (CDC). BMI

20-40 , 40-60 60 , ,

. BMI

, Chi-Square test T-test.

, ,

, .

(0,3x10 = 3 )

14

, , , , . Correlation of Serum and Ionized Calcium in Patients with Calcium Nephrolithiasis. Med Arh. 2014; 68(4): 272-276.

.

,

. , ,

2012.- 2013. . 120 .

.

110 (91,7%), 40 .

106 (88,3%), 14 , 2

, 60 . 2 , Ph ,

, , 2 , 120 .

, ,

. (0,5x10 = 5 )

, , . Hypersensitivity to Aeroallergens in Patients with Nasobronchial Allergy. Med Arh. 2014; 68(2): 86-90.

.

. 2254 , .

"prick testa". (72,7%), a (27,6%).

, (p<0,05).

Dermatophagoides pteronyssinus (27,5%) (21,9%), (18,3%) (10,1%).

, (p=0,022). (15,3%),

(12,6%). .

15

. Dermatophagoides pteronyssinus ,

, .

(10 )

, , . Incidence of Osteoporosis in Patients with Urolithiasis. Med Arh. 2014; 68(5): 335-338.

,

DEXA, . ,

, , . , . 120

3 : 20-40 , 40-60 60 .

, . L2-

L4 DEXA. DEXA ,

, 60 (30% 15%

) (12,5% 20-40 17,5% 40-60 ),

(p<0,05). , ,

37,5% 2,5% 60 , 5% ,

(p<0,05).

(p<0,01), 7,5%, 0,8%.

.

(10 )

, , . Correlation of Parathormone and the Serum Values of Acidum Uricum with Calcium Nephrolithiasis Examined by Three Different Methods of Diagnostics. Acta Inform Med. 2015; 23(3): 132-135.

80% , .

16

( ).

120 , : 20-

40 , 40-60 60 .

, (kidney-ureter-bladder radiography-KUB)/ ( ),

, "non-contrast

CT" (NCCT). .

, 40-60

, .

, , ,

(p>0,05).

, ,

.

(10 )

, , , . Treatment of Bone Defects in War Wounds: Retrospective Study Treatment of Bone Defects in War Wounds: Retrospective Study. Med Arh. 2015; 69(4): 140-144.

.

, .

116 , Ilizarov- .

4 , : 8 (45%), 6 (34%)

4 (21%). 36

(41%), 24 (34%) 16 (25%). 4 : 3 (38%), 3

(38%) 2 (24%). 4 Ilizarov-

17

8 (57%), 3 (21,5%) 3 (21,5%).

4 , 4 Ilizarov-

. (0,75x10 = 7,5 )

, , . Gender Representation of Osteoporosis in Patients with Urolithiasis. Med Arh. 2015; 69(5): 331-333.

.

, DEXA ,

. , ,

. 120 : .

, . ,

3 : 20-40 , 40-60 60 . 63 (52,2%) 57 (47,5%).

72 (60%) 48 (40%). L2-L4 DEXA

.

(14% 22,8%) (1,6% 17,5%).

, (36,1%) (2,1%).

(p<0,01) , /

(36,1%) (4,2%). ,

, ,

. (10 )

, , . Correlation of Osteoporosis and Calcium Urolithiasis in Adult Population. Med Arch. 2016 Feb; 70(1): 67-70.

,

.

18

, DEXA, . ,

. : ,

, . 240 , 120 , : 20-40 , 40-

60 60 . DEXA, L2-

L4 . , ,

DEXA 72,5% , 27,5% , . (p<0.05)

20-40 60 . ,

(p<0.05). DEXA

60 (p<0.05). ,

DEXA 95% , 60% ,

(p<0.01). DEXA , DEXA

. ,

. (10 )

, ( . 19, .13)

.

. . 2016.

/ . 0,1-

2,9%, , ( ) , ,

, , ,

19

. ,

, . , /

, .

, , , .

, , ,

. (8 )

. Impact of Surgical Treatment of Benign Prostatic Hyperplasia on Nocturia, predavanje po pozivu na EPS Global Shanghai International Congress of Urology, Shanghai, China, 16.-17.07.2011.

(LUTS) (BPH). International Continence

Society (ICS) , .

LUTS/BPH : ,

, , . ,

, (ICS)

, .

.

, .

(8 )

. PSA , II Kongresu Udruženja urologa Crne Gore i Udruženja Urologa Srbije, u

Budvi, 12.-15.06.2014.

(PCa) . PCa , ,

. , (PSA)

,

20

. PSA

PCa. PSA, , .

PSA : PCa. PCa PSA

"US prevention study". PSA , PSA PCa. PSA density, PSA density of the transition zone, age-specific

reference range PSA molecular forms. , , complex PSA, proPSA (precursor isoforms of PSA), BPSA (benign PSA), iPSA (intact PSA)

. Index F/TPSA BPH PCa. PCa PSA 4-10

nh/ml . PSA velocity (PSAV) PSA doubling time (PSADT) PCa,

PCa. PSA3 ,

. PSA3 total PSA free PSA PCa PSA.

(8 )

, ; ( . 19, . 41)

ESMO . . ( ,

, , - , , , , ). : ; 2015.

European

Society for Medical Oncology, 20.09.2015.

. , . . .

(0,3x3 = 0,9 )

( . 19, . 30)

. Editorial Comment to Tamsulosin versus transurethral resection of the prostate: Effect on nocturia due to benign prostatic hyperplasia. International Journal of Urology (IJU) 2011; 18(3): 248-249.

21

Simaioforidis V, Chrisofos M, Papatsoris AG, Koritsiadis S,

Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: Effect on nocturia due to benign prostatic hyperplasia International Journal of Urology,

, , "editorial comment" , . (3 )

( . 19, . 38) ( , PubMed- - ) Simaioforidis V, Chrisofos M, Papatsoris AG, Koritsiadis S, Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: Effect on nocturia due to benign prostatic hyperplasia. International Journal of Urology (IJU) 2011; 18(3): 248-249 Influence of theProstate Volume, Prostate Specific Antigen Density and Number of Biopsy Samples on Prostate Cancer Detection. Medical Archives Th Significance of the Influence of Aging and Infravesical Obstruction Caused by Benign Prostatic Enlargement on Detrusor Impairment. Medical Archives Complications and Bladder Cancer Stage Impact on Quality od Life in Patinets with Different Types of Urinary Diversions. Medical Archives Is Bacterial Vaginosis a Risk Factor for Preterm Labour- An Analysis of Age and Duration of Marriage. Medical Archives Efficiency of Local Anriseptic Alkosol (Ethanol, Isopropanol-30g and Ortophenilphenol) and Povidone Iodide on the Incidence of Surgical Siote Infection After Inguinal Hernioplasty. Medical Archives Diagnostic Approach to Patients with Atypical Squamous cells of Undetermined Significance Cytological Findings on Cervix. Medical Archives Low Preterm Birth Rate with Decreasing Early Neonalatal Mortality in Bosnia and Hercegovina during 2007-2014. Medical Archives Assessment of Fatigue in the End Stage Renal Disease Patients Undergoing Hemodialysis: Prevalence and Associated Factors. Medical Archives

22

Platelet Count in Women with Pregnancy Induced Hypertension in University Hospital Center of Mother and Child Health Center Care "Koco Glliozheni" Tirana Albania. Materia Socio Medica Antimicrobial Resistance of Escherichia Colli Strains Isolated from Urine at Outpatient Population: a Single Laboratory Experience. Materia Socio Medica The Effect of Hysterectomy on Womens Sexual Function: A Narrative Review. Acta Informatica Medica Designing and Implementation on Fuzzy Case-based Reasoning system on Android platform using Electronic Discharge summary of patients with chronic kidney diseases. Acta Informatica Medica Prazosin or Pumpkin Seed oil (Prostafit)? Which one is better in the treatment of symptomatic benign prostatic hyperplasia? Urology Journal

. . : - ; 2015.

. . : -

; 2015. (16 x 2 =32 a)

( . 19, . 24)

Editorial Bord Medical Archives. (6 )

( . 19, . 26)

, Scripta Medica.

, KOD.

(2 x 3 =6 )

23

: 407,4

) :

/

.

, , , ,

, , ,

" ", . .

( . 21, . 2)

, - : . ; 2010.

(0,3x6 = 1,8 )

. 15.- : " ", "

", " " " ".

, – :

. ; 2010. (0,3x6 = 1,8 )

. " "", ".

24

, - : . .

; 2005. (0,3x6 =1,8 )

,

, , .

„ “.

( . 21, . 13, 14)

. , –

, . ,

, . 23 2

, , .

( . 21, . 12)

"

. ", , 2010. .

(3 )

/

, ,

,

.

, " ".

25

, 2010. .

( . 21, . 2)

- , , , . . : ; 2013.

.

, .

, , .

.

, . (0,75x6 =4,5 )

. ( ). . : ;

2015.

. ,

. , ,

, . ,

. " " ,

. . " " " ".

(0,3x6 =1,8 )

( . 21, . 17) ESMO , .

. ( , , , , ,

26

, , , , ). : ; 2016.

(ESMO)

, .

. , .

- .

(0,3x3 =0,9 )

( , , , ) ( . 21, . 10)

. How can we optimise treatment of benign prostatic hyperplasia? Regional

Adriatic Meeting of urologists, Ohrid, Macedonia. 2012.

. "How can we optimise treatment of benign prostatic hyperplasia?"

, , , , , , 21.-23. 2012.

(3 )

( . 21, . 18)

" "

, , 2014.

(1 )

( . 21, . 13)

" ",

27

2013. , 2013. . (4 )

, " ",

2016., 2016. .

,

2016. (4 )

" ,

", . (4 )

( . 21, . 14)

" ", 2013. , 2013. . (2 )

( . 21, . 12)

"

", , 05.05.2014.

(3 )

" 3

", 31.04.2013. .

(3 )

28

: 39,6

) :

/

( . 22, . 18)

, .

(14 )

. (2 )

,

, , ,

, .

( . 22, . 20)

.

(7 )

( . 22, . 11)

, . . : ; 2008. (3 )

, . . : ; 2009.

(3 )

Yamanouchi- " ". 2002., .

(3 )

29

( ) ( . 22, . 4)

, , - , , .

omentum flapom. Scripta Medica 2009; 40 (1): 41-45 (0,5x2 = 1 )

( .22, . 5)

- , , , . Uroinfections during pregnancy. 3rd Congress of the South East European Society of Pernatal Medicine.

; 2009:112-13. (0,75x3 =2,25 )

, , . 1999-2004. . XVII

: ; 2005. (3 )

, , , . . XVII

: ; 2005. (0,75x3 =2,25 )

, , , . .

XVII : ; 2005. (0,75x3 =2,25 )

, , . - . XVII :

; 2005. (3 )

, , , . . XVII :

; 2005. (0,75x3 =2,25 )

30

, . carcinoma in situ . Scripta medica 2007:1 (1 Suppl) (0 )

, , . . Scripta medica

2007:1 (1 Suppl) (0 )

, , , , . – . Scripta medica 2007:1 (1 Suppl) 1

(0 )

, , , , , . . Scripta medica 2007:1 (1

Suppl) 1 (0 )

, . . Scripta medica 2007:1 (1 Suppl) (0 )

( / )

( ) ( . 22, . 3)

, , . Encrustation of the Ureteral Double J Stent in Patients with a Solitary Functional Kidney – a Case Report. Med Arh. 2015; 69(4): 140-144.

, . ,

. “Stent syndrome”, ,

. ,

2,5 , 70 , ,

31

. .

(4 )

, , , , , . Testicular Cancer- Case Report of the Patient with Retroperitoneal Advanced Disease. Medical Investigations 2011; 45(1): 13-7.

1-1,5% 5% .

6,3 100 000 , -

10/100 000 . .

, .

20 , . ,

17 11 . .

. , PEB,

(RPLND). "staging"-o , RPLND,

. (0,3x4 =1,2 )

( . 22, . 20)

:

1. , , 2013. 2. , , 2015.

(2x1 =2 )

( . 22, . 18)

32

( ,

). (2 x 2 =4 )

( . 22, . 11)

: " (LUTS) "

, Astellas,

, 2014. .

, ,

, .

(3 )

: " (LUTS) , (BPO)". 2012.

,

, . Guidelines Office EAU, ( ). 2012.

GlaxoSmithCline. (3 )

( . 22, . 22)

.

.

.

33

.

( ).

( ).

,

. (7x2 =14 )

: 79,2

,

197 210,4 407,4

8,4 31,2 39,6

48 31,2 79,2

526,2

34

III.

. , , ,

.

, , , - ,

, u

.

, -

, , ,

.

, 21.05.2016.

:

. , ,

( ), -

. , , ,

-

. , ,

( ), -